Clinical Trial Update: Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke

View source ↗

Summary

A study in atrial fibrillation patients at high risk of stroke has been terminated. The update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Anthos Therapeutics, Inc. | Conditions: Atrial Fibrillation | Status: TERMINATED